Mineralized Bacteria as a Potent Vaccine Against Staphylococcus aureus Infections

Area of Science:

• Immunology
• Materials Science
• Infectious Diseases

Background:

• Staphylococcus aureus is a common Gram-positive bacterium causing severe infections.
• Drug-resistant S. aureus poses significant treatment challenges.
• There is an urgent need for effective S. aureus vaccines.

Purpose of the Study:

• To develop a novel Staphylococcus aureus vaccine (MnO2@FS) using biomineralized manganese dioxide (MnO2) on formaldehyde-fixed S. aureus (FS).
• To investigate the vaccine's ability to activate innate immunity and enhance S. aureus-specific immune responses.

Main Methods:

• Biomineralization of MnO2 onto formaldehyde-fixed S. aureus (FS) to create MnO2@FS vaccine.
• In vitro assessment of MnO2@FS effects on bone marrow-derived dendritic cells (BMDCs).
• In vivo immunization of mice with MnO2@FS and evaluation of immune responses and protection against S. aureus infection.

Main Results:

• MnO2@FS treatment enhanced BMDC uptake of FS and manganese, and increased cytokine secretion.
• Immunization with MnO2@FS significantly boosted S. aureus-specific antibody levels in mice.
• MnO2@FS vaccinated mice demonstrated faster bacterial clearance, higher survival rates in lethal infection models, and controlled abscess development.

Conclusions:

• The novel MnO2@FS vaccine strategy effectively enhances immune responses against Staphylococcus aureus.
• MnO2@FS activates the cGAS-STING pathway and innate immunity, improving vaccine potency.
• This study presents a promising new approach for developing potent and safe bacterial vaccines.